Medicon Valley Alliance and Genscript ProBio are pleased to invite you to a Good Morning Meeting on the 5th of October in Copenhagen focusing on accelerated ADC development via integrated antibody discovery platform.
Key learning objectives:
- Brief overview of history and current trending of antibody-drug conjugates
- Tools and strategies for ADC naked antibody discovery & pharmacology evaluation
- Comprehensive assessment of ADC candidates during discovery stage
Date: Thursday, 5th of October, 2023
Time: 8:30 – 11:00 CET
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 15, 2300 Copenhagen S, Denmark – Meeting room: Auditorium
Program
| 08:30 | Networking, registration, and light breakfast |
| 09:00 | Welcome David Munis Zepernick, Director, Member Engagement & Communication, Medicon Valley Alliance |
| 09:05 | Company Introduction of GenScript ProBio Andre Tavares Fernandes, Sr. Commercial BD Manager of EU BD Dept., Genscript Probio |
| 09:20 | Accelerated ADC development via integrated antibody discovery platform Dr. Chen Li, Sr. Director, Biologics Discovery Dept., Genscript Probio |
| 10:20 | Q&A session |
| 10:30 | Networking |
| 11:00 | End of Good Morning Meeting |
Speakers
 |
Andre Tavares Fernandes, Sr. Commercial BD Manager of EU BD Dept. at GenScript ProBio With MsC in Biotechnological Engineering and PhD in Biochemistry, Andre is here today as a Senior Business Development Manager promoting GenScript ProBio CDMO services both in Biologics and Cell & Gene therapy. Before joining GenScript ProBio, Andre has worked in similar roles providing the In Vitro Diagnostics with raw materials for the production and development of various types of Diagnostic test kits. Currently at GenScript ProBio, he emphasizes not only the Cell & Gene Therapy related products capacity of GenScript ProBio, but also the strong platform GenScript ProBio has for Discovery of new antibody candidates for therapeutic use. |
 |
Dr. Chen Li, Sr. Director, Biologics Discovery Dept. at GenScript ProBio Dr. Chen Li is the Director of Biologics Discovery Department of GenScript ProBio. After obtaining his doctorate in immunology from the University of Massachusetts School of medicine, he joined GenScript in 2015 and has been responsible for antibody drug discovery platform for the past seven years. He has more than 200 project experience in antibody drug discovery and Engineering innovation optimization, as well as three patents related to biopharmaceutical discovery. |
| Organized by | In collaboration with |
 |
 |